Open Access Research article

Budget impact analysis of ustekinumab in the management of moderate to severe psoriasis in Greece

Georgia Avgerinou3, Ioannis Bassukas1, Georgios Chaidemenos2, Andreas Katsampas3, Marita Kosmadaki3, Hara Kousoulakou8*, Athanasios Petridis1, Brad Schenkel9, Dimitrios Sotiriadis4, Theofanis Spiliopoulos5, Panagiotis Stavropoulos3, Evgenia Toumpi6 and Loukas Xaplanteris7

Author Affiliations

1 Department of Skin and Venereal Diseases, University of Ioannina, Ioannina, Greece

2 Department of Dermatology, Hospital for Skin and Venereal Diseases, Thessaloniki, Greece

3 Department of Dermatology, University of Athens, Hospital “A. Syggros”, Athens, Greece

4 Department of Dermatology, Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece

5 Department of Dermatology, University of Patras, Patras, Greece

6 Department of Dermatology and Venereology, “Attikon” General University Hospital, Athens, Greece

7 Janssen Cilag Pharmaceutical SACI, Athens, Greece

8 PRMA Consulting Ltd, Hampshire, UK

9 Janssen Scientific Affairs, LLC, Horsham, PA, USA

For all author emails, please log on.

BMC Dermatology 2012, 12:10  doi:10.1186/1471-5945-12-10

Published: 25 July 2012

Additional files

Additional file 1::

Primary research questionnaire. This is the full 40-item questionnaire which was used both during the face-to-face interviews with the dermatologists and during the expert panel. This is a pdf document and can be viewed with Adobe Acrobat. (PDF 78 kb)

Format: PDF Size: 79KB Download file

This file can be viewed with: Adobe Acrobat Reader

Open Data